|
HY-N2036-1mg
|
MedChemexpress LLC
|
Mosloflavone [CAS 740-33-0]
|
|
COVID-19-anti-virus
|
|
|
HY-N2036-10mg
|
MedChemexpress LLC
|
Mosloflavone [CAS 740-33-0]
|
|
COVID-19-anti-virus
|
|
|
HY-N2036-5mg
|
MedChemexpress LLC
|
Mosloflavone [CAS 740-33-0]
|
|
COVID-19-anti-virus
|
|
|
HY-153810-10mg
|
MedChemexpress LLC
|
Mosnodenvir [CAS 2043343-94-6]
|
|
COVID-19-anti-virus
|
|
|
HY-153810-100mg
|
MedChemexpress LLC
|
Mosnodenvir [CAS 2043343-94-6]
|
|
COVID-19-anti-virus
|
|
|
HY-153810-25mg
|
MedChemexpress LLC
|
Mosnodenvir [CAS 2043343-94-6]
|
|
COVID-19-anti-virus
|
|
|
HY-153810-5mg
|
MedChemexpress LLC
|
Mosnodenvir [CAS 2043343-94-6]
|
|
COVID-19-anti-virus
|
|
|
HY-153810-50mg
|
MedChemexpress LLC
|
Mosnodenvir [CAS 2043343-94-6]
|
|
COVID-19-anti-virus
|
|
|
HY-153810-1mL
|
MedChemexpress LLC
|
Mosnodenvir [CAS 2043343-94-6] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-10229-10mg
|
MedChemexpress LLC
|
Motesanib (Diphosphate) [CAS 857876-30-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-10229-100mg
|
MedChemexpress LLC
|
Motesanib (Diphosphate) [CAS 857876-30-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-10229-50mg
|
MedChemexpress LLC
|
Motesanib (Diphosphate) [CAS 857876-30-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-10229-1mL
|
MedChemexpress LLC
|
Motesanib (Diphosphate) [CAS 857876-30-3] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-10228-10mg
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10228-100mg
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10228-5mg
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10228-50mg
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10228-1mL
|
MedChemexpress LLC
|
Motesanib [CAS 453562-69-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-B1484-100mg
|
MedChemexpress LLC
|
Moxalactam (sodium salt) [CAS 64953-12-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1484-500mg
|
MedChemexpress LLC
|
Moxalactam (sodium salt) [CAS 64953-12-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1484-1mL
|
MedChemexpress LLC
|
Moxalactam (sodium salt) [CAS 64953-12-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-13301-1mg
|
MedChemexpress LLC
|
MPC-3100 [CAS 958025-66-6]
|
|
Cancer-programmed cell death
|
|
|
sc-43501
|
Santa Cruz Biotechnology
|
Taq DNA Polymerase
|
|
|
|
